#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Idiopathic intracranial hypertension Becker's muscular dystrophy Parkinson's disease Waldenstrom's macroglobulinaemia recurrent Mycobacterium abscessus infection Adenocarcinoma gastric Myotonia Herpes simplex Hypotransferrinaemia Rosai-Dorfman syndrome Fragile X syndrome Prostate cancer Angiosarcoma metastatic Bronchiolitis Haemophilia A without inhibitors More trials…

    Learn about Rare Diseases

    Soft tissue sarcoma – Basic Information Short-bowel syndrome – Treatment Ewing’s sarcoma metastatic Ehlers-Danlos syndrome – Trials in Disease Activated PI3 kinase delta syndrome – Basic Information Synovial sarcoma recurrent – Trials in Disease Focal segmental glomerulosclerosis – Treatment Factor VIII deficiency – Basic Information Pleomorphic leiomyosarcoma Rosai-Dorfman syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Kyv-101 A3907 Tolvaptan BLEXIMENIB Vatiquinone Doxylamine Hydrogen Succinate Pentosan Polysulfate Sodium Fludrocortisone Acetate Zipalertinib Thiamine Nitrate Bp Nivolumab Tilsotolimod Sodium Atezolizumab Hmb-001 Milvexian Nebivolol Mps-215 Azelastine Triptorelin Acetate Rocuronium Bromide More therapies…

    Learn about Your Condition

    Coronary artery occlusion Meniscus injury Pemphigus Hypersensitivity Rasmussen encephalitis Haemorrhagic stroke Pneumothorax Follicular thyroid cancer Transplantation complication Small cell carcinoma Macular telangiectasia Paget's disease of the vulva Asymptomatic HIV infection Hypogonadism male Peritonitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dermatitis

  • A study to evaluate the effectiveness of NAV-240 in adults with moderate-to-severe hidradenitis suppurativa

    Recruiting

    2 1 1
    Investigated Diseases:
    • Connective tissue disorder
    • Dermatitis
    • Hidradenitis
    Investigated Drugs:
    • IMB 101
    • Sodium Chloride
    Bulgaria Germany Hungary Poland Romania

  • Study on Ustekinumab and Drug Combination for Patients with Severe, Resistant Inflammatory Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Dermatitis
    Investigated Drugs:
    • Anakinra
    • Secukinumab
    • Adalimumab
    France

  • Study on Dupilumab for Treating Nummular Eczema in Patients

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Dupilumab
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!